Evidence map›Paper›PMID 38900856›Full record

ReviewCirculation research2024

Congenital Vascular and Lymphatic Diseases.

Roy Jung, Chinmay M Trivedi

Abstract readReview
In one paragraph

Review in Circulation research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Mycn regulates vascular development through PI3K signaling pathway in zebrafish.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Lymphatic System Development and Function.Current cardiology reports · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roy JungDivision of Cardiovascular Medicine (R.J., C.M.T.), UMass Chan Medical School; Worcester.
Chinmay M TrivediDivision of Cardiovascular Medicine (R.J., C.M.T.), UMass Chan Medical School; Worcester.ORCID 0000-0002-3544-0474

Funding

Epigenetic regulation of lymphatic developmentR01HL141377 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TRIVEDI, CHINMAY M · 2018 to 2025
$4.1M
Transdisciplinary Training In Cardiovascular ResearchT32HL120823 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DONAHUE, J KEVIN, KIEFE, CATARINA I. · 2014 to 2025
$3.9M
Regulation of Cardiac Development by Chromatin Modifying EnzymesR01HL118100 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TRIVEDI, CHINMAY M · 2013 to 2022
$3.7M
Training in the Molecular Basis of Autoimmunity and AutoinflammationT32AI132152 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Katherine A. Fitzgerald, Ann Marshak-Rothstein · 2018 to 2026
$1.6M
NHLBI NIH HHS R01 HL118100NHLBI NIH HHS R01 HL141377NHLBI NIH HHS T32 HL120823NIAID NIH HHS T32 AI132152
6 · The paper itself

Abstract

Over the past several centuries, the integration of contemporary medical techniques and innovative technologies, like genetic sequencing, have played a pivotal role in enhancing our comprehension of congenital vascular and lymphatic disorders. Nonetheless, the uncommon and complex characteristics of these disorders, especially considering their formation during the intrauterine stage, present significant obstacles in diagnosis and treatment. Here, we review the intricacies of these congenital abnormalities, offering an in-depth examination of key diagnostic approaches, genetic factors, and therapeutic methods.

Indexed as

Lymphatic DiseasesAnimalsGenetic Predisposition to DiseaseHumansLymphatic VesselsVascular DiseasesVascular Malformationscongenital abnormalitiesendothelial cellslymphatic systemneoplasmsvascular malformation

Identifiers

PMID38900856
PMCPMC11192239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.